Related Experiment Video
Updated: Mar 2, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Adenosine-induced apoptosis in glomerular mesangial cells
Zhihui Zhao1, Toros Kapoian, Michelle Shepard
1Nephrology Division, Department of Medicine, Robert Wood Johnson Medical School, New Brunswick, New Jersey 08903, USA.
Background:
Mesangial cell apoptosis is a mechanism of resolution of glomerular hypercellularity in inflammatory forms of glomerular injury in which adenosine (ADO) was shown to play an anti-inflammatory role. This, and the observation that mesangial cell have ADO receptors prompted us to determine whether ADO induces mesangial cell apoptosis and to explore underlying mechanisms.
Methods:
Cultured mouse mesangial cell were incubated in the presence or absence of ADO or ADO receptor agonists (R-PIA, NECA, IB-MECA, CGS26180) or antagonists (DPCPX, DPSPX, MRS1191) for 48 hours. Cell death was assessed by trypan blue exclusion analysis. Apoptosis was assessed by DNA fragmentation, TUNEL staining and flow cytometry.
Results:
ADO and the A3 ADO receptor agonist IB-MECA induced mesangial cell death, which was markedly attenuated by the A3 receptor antagonist MRS1191. The A1 receptor agonist R-PIA, A2 receptor agonist NECA or the A2a receptor agonist CGS-12680 had no effect. The IB-MECA-induced mesangial cell death was due to apoptosis. This occurred via a cAMP independent mechanism. RT-PCR analysis revealed presence of A3, A1 and A2b but lack of A2a receptor transcripts in MC total RNA. Western blot analysis of mesangial cell lysates revealed expression the A3 receptor protein only.
Conclusion:
The observations indicate that ADO induces mesangial cell apoptosis via stimulation of the A3 receptor.
Insights
Adenosine (ADO) induces mesangial cell apoptosis through the A3 receptor, a key mechanism in resolving glomerular hypercellularity during kidney inflammation. This finding offers insights into potential therapeutic targets for glomerular diseases.
Area of Science:
- Nephrology
- Cell Biology
- Pharmacology
Background:
- Mesangial cell apoptosis resolves glomerular hypercellularity in inflammatory kidney injury.
- Adenosine (ADO) exhibits anti-inflammatory properties in glomerular diseases.
- Mesangial cells possess adenosine receptors, suggesting a role for ADO in cell fate.
Purpose of the Study:
- To investigate whether adenosine induces apoptosis in mesangial cells.
- To elucidate the underlying molecular mechanisms of adenosine-induced mesangial cell apoptosis.
- To identify the specific adenosine receptor subtypes involved.
Main Methods:
- Cultured mouse mesangial cells were treated with adenosine or its receptor agonists/antagonists.
- Cell viability was assessed using trypan blue exclusion.
- Apoptosis was quantified via DNA fragmentation, TUNEL staining, and flow cytometry.
- Adenosine receptor expression was analyzed using RT-PCR and Western blotting.
Main Results:
- Adenosine and the A3 receptor agonist IB-MECA induced significant mesangial cell death.
- This cell death was primarily apoptosis and was blocked by the A3 receptor antagonist MRS1191.
- A1, A2, and A2a receptor agonists did not induce apoptosis.
- Mesangial cells expressed A3, A1, and A2b receptor transcripts, but only A3 receptor protein was detected.
- The apoptotic pathway was independent of cyclic AMP (cAMP).
Conclusions:
- Adenosine induces mesangial cell apoptosis predominantly through the activation of the A3 receptor.
- This mechanism is crucial for the resolution of glomerular hypercellularity.
- The findings highlight the A3 adenosine receptor as a potential therapeutic target in inflammatory glomerular diseases.
Related Concept Videos
Acute Kidney Injury II: Pathophysiology
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Antihypertensive Drugs: Direct Renin Inhibitors

